Latest News for: novo

Edit

US approves first GLP-1 pill for weight loss: Novo Nordisk

The Daily Tribune - Bahrain 24 Dec 2025
Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be ...
Edit

Novo Nordisk gets landmark obesity pill approved, with production ‘underway’ in NC

The Herald-Sun 24 Dec 2025
North Carolina will be central to the Danish drugmaker’s efforts to make oral Wegovy a success ... .
Edit

Intense Lilly, Novo rivalry throws India weight-loss drug race wide open

The Times of India 24 Dec 2025
Eli Lilly and Novo ... Novo Nordisk is cutting prices and launching Ozempic.
Edit

US approve Novo Nordisk’s Wegovy pill for weight loss

Muskat Daily 24 Dec 2025
Washington, D.C., US – The US Food and Drug Administration has approved a pill version of the drug Wegovy from Novo Nordisk as a treatment for weight loss ... US-listed shares of Novo jumped 8% after the approval announcement for its Wegovy pill.
Edit

Lilly, Novo lock horns in India's obesity drug race

Kyodo 24 Dec 2025
HYDERABAD, India - Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement ‌their lead in India's booming obesity drug market before cheaper generic versions hit shelves in March next year ... LILLY'S GAIN IS NOVO'S PAIN.
Edit

Novo Nordisk A/S: Wegovy� pill approved in the US as first oral GLP-1 for weight management

Nasdaq Globe Newswire 23 Dec 2025
FDA has approved the Wegovy� pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term ... .
Edit

FDA approves Wegovy weight loss pill from Novo Nordisk

NBC News 23 Dec 2025
The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug ... .
Edit

FDA approves Wegovy weight-loss pill from Novo Nordisk

Usatoday 23 Dec 2025
22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy. The once-daily tablet — called the Wegovy pill — is the first oral version of glucagon-like peptide-1 drugs, or GLP-1s, Novo Nordisk said in a news release.
Edit

Novo Nordisk weight-loss drug wins US approval as a daily pill

Financial Times 23 Dec 2025
Danish company will be first to market with oral obesity treatment but rival Eli Lilly is not far behind ....
Edit

Novo Nordisk Gets US Approval For Wegovy Obesity Pill

NDTV 23 Dec 2025
The approval was based on the results of the Oasis 4 trial, which found people taking a 25 milligram pill once daily lost about 16.6% of their body weight ... .
Edit

Take a pill! Novo Nordisk's Wegovy gets US' nod as daily pill for obesity treatment

The Times of India 23 Dec 2025
Novo Nordisk's popular weight-loss drug Wegovy is now available as a ...
Edit

FDA Approves Daily Pill Version of Novo Nordisk’s Wegovy Weight-Loss Drug

Virtual Jerusalem 23 Dec 2025
The drug, which Novo Nordisk calls simply the Wegovy pill, uses the ...
×